NervGen Pharma Corp. (TSXV:NGEN)
Canada · Delayed Price · Currency is CAD 3.900
+0.080 (2.09%)
Oct 24, 2025, 2:00 PM EDT
NervGen Pharma Employees
NervGen Pharma had 7 employees as of December 31, 2019.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
280.42M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2019 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,000 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| Trulieve Cannabis | 6,000 |
| Curaleaf Holdings | 5,519 |
| Green Thumb Industries | 4,800 |
| Verano Holdings | 3,800 |
| WELL Health Technologies | 1,507 |
NervGen Pharma News
- 2 months ago - NervGen Pharma Reports Second Quarter Financial Results and Provides Letter to Shareholders - Newsfile Corp
- 2 months ago - NervGen Pharma's NVG-291-R Demonstrates Significant Functional Recovery in Department of Defense-Sponsored Preclinical Models of Traumatic Hearing Loss and Peripheral Nerve Injury - Newsfile Corp
- 3 months ago - NervGen Pharma announces CEO transition - Seeking Alpha
- 3 months ago - NervGen Announces Leadership Transition to Support Strategic Growth and Expansion - Newsfile Corp
- 3 months ago - NervGen Provides Quarterly "At-The-Market" Equity Program and Grant of Options Update - Newsfile Corp
- 4 months ago - NervGen Strengthens Board Leadership to Accelerate Clinical and Corporate Growth - Newsfile Corp
- 4 months ago - NervGen Announces Clinical Leadership Transition as NVG-291 Continues to Advance Toward Late-Stage Development and Regulatory Milestones - Newsfile Corp
- 4 months ago - NervGen Announces Appointment of Randall Kaye, MD to Chief Medical Advisor Role - Newsfile Corp